178 results on '"Drozynska, Elzbieta"'
Search Results
2. Development and validation of a high-performance liquid chromatographic method with a fluorescence detector for the analysis of epirubicin in human urine and plasma, and its application in drug monitoring
3. Role of HLA match on results of hematopoietic stem cell transplantations from unrelated donors in children with acute leukemia and bone marrow failure syndromes
4. Determination of urinary biogenic amines’ biomarker profile in neuroblastoma and pheochromocytoma patients by MEKC method with preceding dispersive liquid–liquid microextraction
5. Analytical approach to determining human biogenic amines and their metabolites using eVol microextraction in packed syringe coupled to liquid chromatography mass spectrometry method with hydrophilic interaction chromatography column
6. Supplementary Figure 1, Tables 1-3 from miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples
7. Cyclodextrin-modified MEKC method for quantification of selected acidic metabolites of catecholamines in the presence of various biogenic amines. Application to diagnosis of neuroblastoma
8. Zakażenia gronkowcowe u dzieci z chorobami nowotworowymi lub poddawanych przeszczepieniu komórek krwiotwórczych
9. Elevated hemoglobin concentration in 3 children with HFE mutation
10. Hemochromatoza HFE u dzieci – problem niedoceniany
11. Prognostic significance of HER2 expression in neuroblastic tumors
12. Recommendations of procedures to follow in the case of ovarian lesions in girls
13. Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias
14. Isolated central nervous system relapses in patients with high-risk neuroblastoma. Clinical presentation and prognosis: experience of the Polish Pediatric Solid Tumors Study Group.
15. Development of treatment and clinical results in childhood acute myeloid leukemia in Poland
16. Pandemic (H1N1) 2009 influenza — real threat or unjustified panic? The experience of one pediatric hematology-oncology center
17. Expression and significance of HER family receptors in neuroblastic tumors
18. Multiple primary cranio-spinal tumours in a 13-year-old female with neurofibromatosis type 2 management strategy
19. Glomerular filtration rate and prevalence of chronic kidney disease in Wilms' tumour survivors
20. Rola radioterapii w leczeniu zlokalizowanej postaci nowotworów tkanek miękkich u dzieci
21. Factors Predicting Survival in Childhood Malignant and Intermediate Vascular Tumors: Retrospective Analysis of the Polish and German Cooperative Paediatric Soft Tissue Sarcoma Study Groups and Review of the Literature
22. Poor-risk high-grade gliomas in three survivors of childhood acute lymphoblastic leukaemia—an overview of causative factors and possible therapeutic options
23. Sarcomas in children with neurofibromatosis type 1—poor prognosis despite aggressive combined therapy in four patients treated in a single oncological institution
24. Prevalence, Epidemiology, Etiology, and Sensitivity of Invasive Bacterial Infections in Pediatric Patients Undergoing Oncological Treatment: A Multicenter Nationwide Study
25. WHEN BIOPSY OF THE TUMOUR IS NECESSARY TO DIAGNOSE TUBERCULOSIS
26. High Frequency of Fusion Gene Transcript Resulting From t(10;11)(p12;q23) Translocation in Pediatric Acute Myeloid Leukemia in Poland
27. Retrospective Analysis of the Treatment Outcome in Myeloid Leukemia of Down Syndrome in Polish Pediatric Leukemia and Lymphoma Study Group From 2005 to 2019
28. WAS SPLENECTOMY NECESSARY FOR DIAGNOSIS OF YERSINIOSIS IN AN 18-YEAR-OLD PATIENT?
29. NEUROGENIC TUMORS IN CHILDREN. REPORT OF POLISH PEDIATRIC SOLID TUMOR GROUP (PPSTG): P.D.130
30. Malignant neoplasms of parameningeal region in children – report from two paediatric centres of oncology
31. The first reported case of G6PD deficiency due to Seoul mutation in Poland
32. Anemia secondary to valproic acid therapy in a 13-year-old boy: a case report
33. Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma
34. The role of genotyping in secondary malignant gliomas in survivors of childhood acute lymphoblastic leukaemia
35. Infectious complications in children treated for hodgkin and non-hodgkin lymphomas in polish pediatric leukemia/lymphoma study group: incidence, epidemiology and etiology
36. Safety of Intravenous Application of Second-Generation Ultrasound Contrast Agent in Children: Prospective Analysis
37. Parental knowledge and metabolic control of children and young adults with type 1 diabetes
38. Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study
39. HFE Gene Mutations and Iron Status in 100 Healthy Polish Children
40. Reduction of Skeletal Muscle Power in Adolescent Males Carrying H63D Mutation in theHFEGene
41. [Characteristics of extracranial malignant germ cell tumours in two age groups of children (0-10 and 10-18 years). Multicentre experiences]
42. Differential in Vitro Drug Resistance Profile Between First and Second Relapsed Acute Lymphoblastic Leukemia and Acute Myeloblastic Leukemia in Children
43. A need for cautious interpretation of elevated serum germ cell tumor markers in children. Review and own experiences
44. Improvement of the Treatment Results in Childhood Acute Myeloid Leukemia in Poland from 1983 to 2017
45. [Influence of age on treatment results in children and adolescents with Hodgkin's disease]
46. Infectious Complications in Children with ALL Treated with ALL-IC-2009 Protocol: Multicenter National Study of Polish Society of Pediatric Hematology and Oncology
47. The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I/II clinical trials
48. The first reported case of G6PD deficiency due to Seoul mutation in Poland
49. Serum IL-10 and IL-12 levels reflect the response to chemotherapy but are influenced by G-CSF therapy and sepsis in children with soft tissue sarcomas
50. Deregulated systemic IL-10/IL-12 balance in advanced and poor prognosis paediatric soft tissue sarcomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.